Immunotherapy-boosted chemo shows striking early results against high-risk nasopharyngeal cancer
A prospective phase II pilot study from non-endemic Sichuan reports 95.2 percent response rates and 80 percent event-free survival at ...
A prospective phase II pilot study from non-endemic Sichuan reports 95.2 percent response rates and 80 percent event-free survival at ...
A retrospective Munich study of 116 AML patients found arm-inserted PICCs stayed in place longer and caused fewer exit site ...
A Swedish prospective study is tracking anti-Müllerian hormone levels in girls with cancer from diagnosis to age 25 to identify ...
A new systematic review and meta-analysis of 20 studies finds that 61 percent of cancer patients resume some anticancer treatment ...
A prospective Hungarian study of 50 breast cancer patients found the PAXMAN scalp cooling system preserved hair in 69% of ...
A sweeping review reveals how the chemotherapy drug doxorubicin breaks the heart's mitochondrial and ER recycling systems at multiple checkpoints, ...
A real-world study finds that every patient treated with zolbetuximab for CLDN18.2-positive advanced gastric cancer developed hypoalbuminemia, with prior total ...
A machine-learning analysis of a randomized controlled trial shows that both transcutaneous electrical acupoint stimulation and self-acupressure significantly increase the ...
A nationwide analysis of 8,104 Hungarian patients treated from 2013 to 2022 shows median survival of just 9.3 months with ...
A new case series documents three girls whose early puberty and excessive thirst revealed rare β-hCG-secreting brain tumors, prompting calls ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine